Population Screening for Von Willebrand Disease in Adolescents with Heavy Menstrual Bleeding - 25/10/14
Doi : 10.1016/j.jpeds.2014.09.026
Deena Khamees, MLS, BS 1, ∗, Jennifer Klima, PhD 2, Sarah H. O'Brien, MD, MSc 3, ⁎∗ 
1 Ohio State University College of Medicine, Columbus, OH
2 Center for Innovation in Pediatric Practice, Research Institute at Nationwide Children's Hospital, Columbus, OH
3 Division of Pediatric Hematology/Oncology, Ohio State University College of Medicine, Columbus, OH
∗Reprint requests: Sarah H. O'Brien, MD, MSc, Research Institute at Nationwide Children's Hospital, 700 Children's Dr, ED553, Columbus, OH 43205.
Sous presse. Épreuves corrigées par l'auteur.
Disponible en ligne depuis le Saturday 25 October 2014
Abstract |
We used Ohio Medicaid data to determine frequency and predictors of laboratory screening for von Willebrand disease and other bleeding disorders in adolescents with heavy menses. Despite expert guidelines, screening was performed in only a minority of subjects (<15% of those with heavy menses and <25% of those with menstrual bleeding defined as severe), with younger adolescents and those from more urban counties more likely to undergo screening.
Le texte complet de cet article est disponible en PDF.Keyword : ACOG, ICD-9-CM, VWD
Plan
| Supported by the Samuel J. Roessler Memorial Scholarship. The authors declare no conflicts of interest. |
© 2014
Elsevier Inc. Tous droits réservés.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?